Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SCNX Scienture Holdings, Inc.

未开盘 09-30 16:00:00 EDT

0.2598

-0.0068

-2.55%

盘后0.2095

-0.0503-19.36%

19:54 EDT

最高0.2708	最低0.2524	成交量62.83万
今开0.2666	昨收0.2666	日振幅6.90%
总市值1,067万	流通市值831.28万	总股本4,106万
成交额15.85万	换手率1.96%	流通股本3,200万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.2598,"timestamp":1790798400000,"preClose":0.2666,"halted":0,"volume":628272,"hourTrading":{"tag":"盘后","latestPrice":0.2095,"preClose":0.2598,"latestTime":"19:54 EDT","volume":335947,"amount":73533.12378,"timestamp":1790812447337,"change":-0.0503,"changeRate":-0.19361,"amplitude":0.275597},"delay":0,"changeRate":-0.025506376594148644,"floatShares":31996800,"shares":41064146,"eps":-2.03,"marketStatus":"未开盘","change":-0.0068,"latestTime":"09-30 16:00:00 EDT","open":0.2666,"high":0.2708,"low":0.2524,"amount":158457.8004912,"amplitude":0.069017,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.03,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.2666,"preHourTrading":{"tag":"盘前","latestPrice":0.2601,"preClose":0.2666,"latestTime":"09:07 EDT","volume":24963,"amount":6806.79451242,"timestamp":1790773647063,"change":-0.0065,"changeRate":-0.024381,"amplitude":0.088522},"postHourTrading":{"tag":"盘后","latestPrice":0.2095,"preClose":0.2598,"latestTime":"19:54 EDT","volume":335947,"amount":73533.12378,"timestamp":1790812447337,"change":-0.0503,"changeRate":-0.19361,"amplitude":0.275597},"volumeRatio":1.205006},"requestUrl":"/m/hq/s/SCNX","defaultTab":"news","newsList":[{"id":"1161955625","title":"Scienture携手分销伙伴，将Rezenopy™商业版图拓展至成瘾治疗中心","url":"https://stock-news.laohu8.com/highlight/detail?id=1161955625","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161955625?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:18","pubTimestamp":1790079505,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.近日宣布，已与一家分销合作伙伴达成协议，旨在扩大Rezenopy™在成瘾治疗领域的商业覆盖范围。这一战略举措，标志着该公司正着力深化其产品在专业医疗渠道的渗透力，进一步巩固市场地位。通过此番合作，Rezenopy™将更便捷地触达相关治疗机构，从而为有需要的患者群体提供更高效的支持。此举不仅彰显了Scienture对拓展业务版图的坚定决心，也反映了其在专业健康领域持续布局的长期愿景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112132128","title":"Scienture Holdings Q2 2026业绩出炉：营收环比暴增约510%，运营表现显著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1112132128","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112132128?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:09","pubTimestamp":1786709350,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日公布了2026年第二季度财务报告。与第一季度相比，公司营收实现了令人瞩目的飞跃——环比增幅高达约510%。与此同时，运营绩效也呈现出显著的优化态势。具体而言，Scienture在第二季度不仅成功扭转了此前季度相对疲软的增长态势，更在成本控制与业务结构优化上取得了实质性突破。尽管当前宏观环境仍存变数，但Scienture凭借这一季度的超预期表现，已向投资者展示了其强劲的成长韧性与执行能力。此次财报，或将成为公司估值重塑的关键催化剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198130031","title":"Scienture宣布Rezenopy™正式上市，首批订单已交付——这是FDA批准的最高剂量纳洛酮鼻喷雾剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1198130031","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198130031?lang=zh_cn&edition=full","pubTime":"2026-08-12 20:06","pubTimestamp":1786536370,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.今日发布公告，正式启动Rezenopy™的商业化上市，并已完成首批采购订单的履约交付。Rezenopy™作为美国食品药品监督管理局（FDA）批准的最高剂量纳洛酮鼻喷雾剂，标志着公司在阿片类药物过量逆转领域迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197083931","title":"Scienture公布2026年第一季度财报：营收强劲增长，毛利率显著扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=1197083931","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197083931?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:39","pubTimestamp":1779107951,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.发布了2026年第一季度财务业绩及业务进展。报告期内，公司实现了显著的营收增长，同时毛利率亦获得有力扩张，展现出强劲的业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143008554","title":"Scienture Holdings与Summit Biosciences达成最终协议 获得Rezenopy美国独家商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=1143008554","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143008554?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:14","pubTimestamp":1778156056,"startTime":"0","endTime":"0","summary":"Scienture Holdings已与Summit Biosciences签署最终协议，获得抗抑郁药物Rezenopy在美国市场的独家商业化权利。此次合作将进一步加强Scienture Holdings在神经科学领域的市场布局。\n根据协议条款，Scienture Holdings将负责Rezenopy在美国境内的所有商业化活动，包括市场推广、销售和分销。该交易标志着公司向精神健康治疗领域迈出重要一步。\nRezenopy作为一种新型抗抑郁药物，在临床试验中展现出良好的疗效和安全性。此次独家授权协议的达成，将为Scienture Holdings带来新的收入增长点，并扩大其产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178090977","title":"Scienture获得1100万美元非稀释性债务融资 加速已获批产品组合扩张及研发管线推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1178090977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178090977?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:06","pubTimestamp":1778155590,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (简称Scienture) 近日成功获得1100万美元非稀释性债务融资。此次融资将主要用于加速公司已获批产品组合的商业化增长，并推动研发管线的持续进展。非稀释性融资模式使得Scienture能够在不动用股权的情况下获得资金支持，有效保护了现有股东利益。这笔资金将助力公司扩大市场份额，加强产品创新，为长期发展注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164857739","title":"Scienture Holdings获纳斯达克180天宽限期 需在此期间恢复最低股价合规要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1164857739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164857739?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:05","pubTimestamp":1776254717,"startTime":"0","endTime":"0","summary":"纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期，该公司须在此期间内将其股价提升至1美元以上，以满足交易所的最低报价规定。\n此次延期为这家生物科技企业提供了关键缓冲期，使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规，公司将面临退市风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":-0.1032},{"period":"1month","weight":-0.3313},{"period":"3month","weight":-0.2448},{"period":"6month","weight":-0.1232},{"period":"1year","weight":-0.6942},{"period":"ytd","weight":-0.4906}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Scienture Holdings, Inc.于2005年7月15日在特拉华州注册成立。该公司的主要运营子公司是Scienture，LLC。Scienture LLC是一家专业制药公司，专注于心血管（“CVS”）和中枢神经系统（“CNS”）疾病治疗产品的商业化和开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.09045},{"month":6,"riseRate":0.857143,"avgChangeRate":0.461559},{"month":7,"riseRate":0.714286,"avgChangeRate":0.094869},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.141065},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.088428},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Scienture Holdings, Inc.(SCNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}